{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:41:31Z","timestamp":1784241691988,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Child Adolesc Psychiatry Ment Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adolescents are increasingly using classical psychedelics, yet little is known about how psychedelics use is related to their mental health. Emerging evidence suggests that adolescents may be more vulnerable to adverse outcomes in relation to psychedelic use compared to adults. This descriptive and exploratory study examined differences between adolescents and adults in reported psychedelic experiences, with a focus on adverse outcomes and the potential role of personality traits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data were drawn from a community sample (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u20091185), in which participants retrospectively reported on their most significant psychedelic experience and associations with adverse (e.g., confusion) and positive outcomes (e.g., meaningfulness). The sample was divided into adolescents aged 18\u201324 years and adults aged 25 years or older. Age groups were analysed both dichotomously (&lt;\u200925 vs. \u226525 years) and continuously. Analyses of covariance (ANCOVA) and linear regressions were used to test the role of age and personality traits as predictors of adverse outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Adolescents reported significantly more adverse outcomes compared to adults, including more negative personality change as well as more fearful experiences. Positive outcomes such as meaningfulness, mystical-type experiences, and improvements in relationships did not differ significantly between age groups. Age group remained a significant predictor of adverse outcomes after adjusting for personality traits. Neuroticism explained a substantially larger share of variance compared to age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that while adolescents may derive similar positive effects from psychedelics as adults, they may be more vulnerable to adverse outcomes. The findings underscore the need for further longitudinal research to understand how developmental stages and individual differences influence psychedelic use outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13034-026-01048-x","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:18:39Z","timestamp":1771924719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits"],"prefix":"10.1186","volume":"20","author":[{"given":"David","family":"Sj\u00f6str\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Claesdotter-Knutsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"Kajonius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"2","key":"1048_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1021\/acsptsci.1c00014","volume":"4","author":"JS Aday","year":"2021","unstructured":"Aday JS, Davis AK, Mitzkovitz CM, Bloesch EK, Davoli CC. Predicting reactions to psychedelic drugs: A systematic review of States and traits related to acute drug effects. ACS Pharmacol Transl Sci. 2021;4(2):424\u201335. https:\/\/doi.org\/10.1021\/acsptsci.1c00014.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"1048_CR2","doi-asserted-by":"publisher","first-page":"15998","DOI":"10.1038\/s41598-023-41145-x","volume":"13","author":"R Bremler","year":"2023","unstructured":"Bremler R, Katati N, Shergill P, Erritzoe D, Carhart-Harris RL. Case analysis of long-term negative psychological responses to psychedelics. Sci Rep. 2023;13(1):15998. https:\/\/doi.org\/10.1038\/s41598-023-41145-x.","journal-title":"Sci Rep"},{"key":"1048_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/frcha.2024.1364617","volume":"3","author":"N Izmi","year":"2024","unstructured":"Izmi N, Carhart-Harris RL, Kettner H. Psychological effects of psychedelics in adolescents. Front Child Adolesc Psychiatry. 2024;3:1364617. https:\/\/doi.org\/10.3389\/frcha.2024.1364617.","journal-title":"Front Child Adolesc Psychiatry"},{"key":"1048_CR4","doi-asserted-by":"publisher","first-page":"173129","DOI":"10.1016\/j.pbb.2021.173129","volume":"203","author":"MLS Bates","year":"2021","unstructured":"Bates MLS, Trujillo KA. Use and abuse of dissociative and psychedelic drugs in adolescence. Pharmacol Biochem Behav. 2021;203:173129. https:\/\/doi.org\/10.1016\/j.pbb.2021.173129.","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"1048_CR5","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1111\/add.16259","volume":"118","author":"KM Keyes","year":"2023","unstructured":"Keyes KM, Patrick ME. Hallucinogen use among young adults ages 19\u201330 in the United States: changes from 2018 to 2021. Addiction. 2023;118(12):2449\u201354. https:\/\/doi.org\/10.1111\/add.16259.","journal-title":"Addiction"},{"issue":"12","key":"1048_CR6","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1111\/add.15987","volume":"117","author":"O Livne","year":"2022","unstructured":"Livne O, Shmulewitz D, Walsh C, Hasin DS. Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP. Addiction. 2022;117(12):3099\u2013109. https:\/\/doi.org\/10.1111\/add.15987.","journal-title":"Addiction"},{"issue":"3","key":"1048_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S2352-4642(18)30022-1","volume":"2","author":"SM Sawyer","year":"2018","unstructured":"Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018;2(3):223\u20138. https:\/\/doi.org\/10.1016\/S2352-4642(18)30022-1.","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"1048_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1037\/0003-066X.55.5.469","volume":"55","author":"JJ Arnett","year":"2000","unstructured":"Arnett JJ. Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol. 2000;55(5):469\u201380. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10842426.","journal-title":"Am Psychol"},{"issue":"9","key":"1048_CR9","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nn.3177","volume":"15","author":"SJ Blakemore","year":"2012","unstructured":"Blakemore SJ, Robbins TW. Decision-making in the adolescent brain. Nat Neurosci. 2012;15(9):1184\u201391. https:\/\/doi.org\/10.1038\/nn.3177.","journal-title":"Nat Neurosci"},{"key":"1048_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1196\/annals.1440.010","volume":"1124","author":"BJ Casey","year":"2008","unstructured":"Casey BJ, Jones RM, Hare TA. The adolescent brain. Ann N Y Acad Sci. 2008;1124:111\u201326. https:\/\/doi.org\/10.1196\/annals.1440.010.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1048_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/nyas.15314","volume":"1546","author":"BJ Casey","year":"2025","unstructured":"Casey BJ, Cohen AO, Galvan A. The beautiful adolescent brain: an evolutionary developmental perspective. Ann N Y Acad Sci. 2025;1546(1):58\u201374. https:\/\/doi.org\/10.1111\/nyas.15314.","journal-title":"Ann N Y Acad Sci"},{"key":"1048_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.euroneuro.2022.09.004","volume":"64","author":"M Solmi","year":"2022","unstructured":"Solmi M, Chen C, Daure C, Buot A, Ljuslin M, Verroust V, et al. A century of research on psychedelics: a scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs. Eur Neuropsychopharmacol. 2022;64:44\u201360. https:\/\/doi.org\/10.1016\/j.euroneuro.2022.09.004.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1048_CR13","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.neubiorev.2022.104793","volume":"140","author":"M van Elk","year":"2022","unstructured":"van Elk M, Yaden DB. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. Neurosci Biobehav Rev. 2022;140:104793. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104793.","journal-title":"Neurosci Biobehav Rev"},{"key":"1048_CR14","unstructured":"Welfare A. I. o. H. a. 2024. Hallucinogens in the NDSHS. https:\/\/www.aihw.gov.au\/reports\/illicit-use-of-drugs\/hallucinogens-ndshs"},{"key":"1048_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-025-01481-7","author":"DK Sjostrom","year":"2025","unstructured":"Sjostrom DK, Claesdotter-Knutsson E, Gripe I, Kajonius PJ. Adolescent psychedelic use and mental health is associated with user personality: A representative National study on drug use. Int J Ment Health Addict. 2025. https:\/\/doi.org\/10.1007\/s11469-025-01481-7.","journal-title":"Int J Ment Health Addict"},{"issue":"6","key":"1048_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jamapsychiatry.2024.0047","volume":"81","author":"O Simonsson","year":"2024","unstructured":"Simonsson O, Mosing MA, Osika W, Ullen F, Larsson H, Lu Y, et al. Adolescent psychedelic use and psychotic or manic symptoms. JAMA Psychiatr. 2024;81(6):579\u201385. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.0047.","journal-title":"JAMA Psychiatr"},{"issue":"11\u201312","key":"1048_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1159\/000509377","volume":"105","author":"S Dhein","year":"2020","unstructured":"Dhein S. Different effects of cannabis abuse on adolescent and adult brain. Pharmacology. 2020;105(11\u201312):609\u201317. https:\/\/doi.org\/10.1159\/000509377.","journal-title":"Pharmacology"},{"issue":"10","key":"1048_CR18","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41386-024-01891-6","volume":"49","author":"N Ertl","year":"2024","unstructured":"Ertl N, Freeman TP, Mokrysz C, Ofori S, Borissova A, Petrilli K, Curran HV, Lawn W, Wall MB. Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks. Neuropsychopharmacology. 2024;49(10):1640\u201351. https:\/\/doi.org\/10.1038\/s41386-024-01891-6.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1048_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00406-019-00981-7","volume":"269","author":"C Gorey","year":"2019","unstructured":"Gorey C, Kuhns L, Smaragdi E, Kroon E, Cousijn J. Age-related differences in the impact of cannabis use on the brain and cognition: a systematic review. Eur Arch Psychiatry Clin Neurosci. 2019;269(1):37\u201358. https:\/\/doi.org\/10.1007\/s00406-019-00981-7.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"23","key":"1048_CR20","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219\u201327. https:\/\/doi.org\/10.1056\/NEJMra1402309.","journal-title":"N Engl J Med"},{"key":"1048_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jpeds.2018.12.033","volume":"208","author":"XI Liu","year":"2019","unstructured":"Liu XI, Schuette P, Burckart GJ, Green DJ, La J, Burnham JM, Rakhmanina N, Robb A, Huang SM, van den Anker JN. A comparison of pediatric and adult safety studies for antipsychotic and antidepressant drugs submitted to the united States food and drug administration. J Pediatr. 2019;208:236\u201342. https:\/\/doi.org\/10.1016\/j.jpeds.2018.12.033. e233.","journal-title":"J Pediatr"},{"issue":"7","key":"1048_CR22","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s00787-025-02688-8","volume":"34","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Gao Y, Li X, Zou Y, Ye Y, Zou Z. Antidepressant treatment of depression in children and adolescents: a systematic review and dose-response meta-analysis. Eur Child Adolesc Psychiatry. 2025;34(7):1979\u201390. https:\/\/doi.org\/10.1007\/s00787-025-02688-8.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"9","key":"1048_CR23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","volume":"5","author":"S Cortese","year":"2018","unstructured":"Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727\u201338. https:\/\/doi.org\/10.1016\/S2215-0366(18)30269-4.","journal-title":"Lancet Psychiatry"},{"key":"1048_CR24","doi-asserted-by":"publisher","first-page":"1199642","DOI":"10.3389\/fpsyt.2023.1199642","volume":"14","author":"SM Nayak","year":"2023","unstructured":"Nayak SM, Jackson H, Sepeda ND, Mathai DS, So S, Yaffe A, Zaki H, Brasher TJ, Lowe MX, Jolly DRP, Barrett FS, Griffiths RR, Strickland JC, Johnson MW, Jackson H, Garcia-Romeu A. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. Front Psychiatry. 2023;14:1199642. https:\/\/doi.org\/10.3389\/fpsyt.2023.1199642.","journal-title":"Front Psychiatry"},{"issue":"4","key":"1048_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/02791072.2022.2133757","volume":"55","author":"J Weleff","year":"2023","unstructured":"Weleff J, Akiki TJ, Barnett BS. Bibliometric analysis of academic journal articles reporting results of psychedelic clinical studies. J Psychoact Drugs. 2023;55(4):434\u201344. https:\/\/doi.org\/10.1080\/02791072.2022.2133757.","journal-title":"J Psychoact Drugs"},{"issue":"5","key":"1048_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bpsc.2024.01.007","volume":"9","author":"F Holze","year":"2024","unstructured":"Holze F, Singh N, Liechti ME, D\u2019Souza DC. Serotonergic psychedelics: A comparative review of Efficacy, Safety, Pharmacokinetics, and binding profile. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024;9(5):472\u201389. https:\/\/doi.org\/10.1016\/j.bpsc.2024.01.007.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"1048_CR27","doi-asserted-by":"publisher","first-page":"115880","DOI":"10.1016\/j.psychres.2024.115880","volume":"335","author":"B Romeo","year":"2024","unstructured":"Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A. Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review. Psychiatry Res. 2024;335:115880. https:\/\/doi.org\/10.1016\/j.psychres.2024.115880.","journal-title":"Psychiatry Res"},{"key":"1048_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16245147","author":"H Kettner","year":"2019","unstructured":"Kettner H, Gandy S, Haijen E, Carhart-Harris RL. From egoism to ecoism: psychedelics increase nature relatedness in a state-mediated and context-dependent manner. Int J Environ Res Public Health. 2019. https:\/\/doi.org\/10.3390\/ijerph16245147.","journal-title":"Int J Environ Res Public Health"},{"key":"1048_CR29","doi-asserted-by":"publisher","first-page":"749788","DOI":"10.3389\/fpsyg.2021.749788","volume":"12","author":"B Weiss","year":"2021","unstructured":"Weiss B, Nygart V, Pommerencke LM, Carhart-Harris RL, Erritzoe D. Examining Psychedelic-Induced changes in social functioning and connectedness in a naturalistic online sample using the Five-Factor model of personality. Front Psychol. 2021;12:749788. https:\/\/doi.org\/10.3389\/fpsyg.2021.749788.","journal-title":"Front Psychol"},{"key":"1048_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2024.12.001","author":"S Dotson","year":"2024","unstructured":"Dotson S, Luccarelli J. Psychedelic therapeutics for adolescents: ethics, safety, opportunities, and equipoise. J Am Acad Child Adolesc Psychiatry. 2024. https:\/\/doi.org\/10.1016\/j.jaac.2024.12.001.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"12","key":"1048_CR31","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.jaac.2024.03.021","volume":"63","author":"JK Jeffrey","year":"2024","unstructured":"Jeffrey JK, Weintraub MJ, Grob CS. Clinical research trials of psychedelic-assisted therapy in adolescents aged 16 to 17 years: rationale balanced with caution. J Am Acad Child Adolesc Psychiatry. 2024;63(12):1196\u20138. https:\/\/doi.org\/10.1016\/j.jaac.2024.03.021.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"1048_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/02791072.2005.10399792","volume":"37","author":"DX Da Silveira","year":"2005","unstructured":"Da Silveira DX, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, et al. Ayahuasca in adolescence: a preliminary psychiatric assessment. J Psychoactive Drugs. 2005;37(2):129\u201333. https:\/\/doi.org\/10.1080\/02791072.2005.10399792.","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"1048_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/02791072.2005.10399794","volume":"37","author":"E Doering-Silveira","year":"2005","unstructured":"Doering-Silveira E, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, et al. Report on psychoactive drug use among adolescents using ayahuasca within a religious context. J Psychoactive Drugs. 2005;37(2):141\u20134. https:\/\/doi.org\/10.1080\/02791072.2005.10399794.","journal-title":"J Psychoactive Drugs"},{"key":"1048_CR34","doi-asserted-by":"publisher","unstructured":"McCrae RR, Costa PT. Personality trait structure as a human universal. Am Psychol. 1997;52(5):509\u201316. https:\/\/doi.org\/10.1037\/\/0003-066x.52.5.509.","DOI":"10.1037\/\/0003-066x.52.5.509"},{"issue":"2","key":"1048_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5964\/ejop.v15i2.1671","volume":"15","author":"PJ Kajonius","year":"2019","unstructured":"Kajonius PJ, Johnson JA. Assessing the structure of the five factor model of personality (IPIP-NEO-120) in the public domain. Eur J Psychol. 2019;15(2):260\u201375. https:\/\/doi.org\/10.5964\/ejop.v15i2.1671.","journal-title":"Eur J Psychol"},{"issue":"1","key":"1048_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33996-1","volume":"13","author":"W Kang","year":"2023","unstructured":"Kang W, Steffens F, Pineda S, Widuch K, Malvaso A. Personality traits and dimensions of mental health. Sci Rep. 2023;13(1):7091. https:\/\/doi.org\/10.1038\/s41598-023-33996-1.","journal-title":"Sci Rep"},{"key":"1048_CR37","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2025.00414","author":"PJ Kajonius","year":"2025","unstructured":"Kajonius PJ, Sj\u00f6str\u00f6m D, Claesdotter-Knutsson E. Big five personality and the psychedelic experience: an initial report. J Psychedelic Stud. 2025. https:\/\/doi.org\/10.1556\/2054.2025.00414.","journal-title":"J Psychedelic Stud"},{"issue":"2","key":"1048_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030800","volume":"7","author":"E Studerus","year":"2012","unstructured":"Studerus E, Gamma A, Kometer M, Vollenweider FX. Prediction of psilocybin response in healthy volunteers. PLoS One. 2012;7(2):e30800. https:\/\/doi.org\/10.1371\/journal.pone.0030800.","journal-title":"PLoS One"},{"issue":"2","key":"1048_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1037\/a0021717","volume":"100","author":"CJ Soto","year":"2011","unstructured":"Soto CJ, John OP, Gosling SD, Potter J. Age differences in personality traits from 10 to 65: big five domains and facets in a large cross-sectional sample. J Pers Soc Psychol. 2011;100(2):330\u201348. https:\/\/doi.org\/10.1037\/a0021717.","journal-title":"J Pers Soc Psychol"},{"issue":"1","key":"1048_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60890-1","volume":"14","author":"DK Sjostrom","year":"2024","unstructured":"Sjostrom DK, Claesdotter-Knutsson E, Kajonius PJ. Personality traits explain the relationship between psychedelic use and less depression in a comparative study. Sci Rep. 2024;14(1):10195. https:\/\/doi.org\/10.1038\/s41598-024-60890-1.","journal-title":"Sci Rep"},{"issue":"4","key":"1048_CR41","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3758\/s13428-021-01694-3","volume":"54","author":"E Peer","year":"2022","unstructured":"Peer E, Rothschild D, Gordon A, Evernden Z, Damer E. Data quality of platforms and panels for online behavioral research. Behav Res Methods. 2022;54(4):1643\u201362. https:\/\/doi.org\/10.3758\/s13428-021-01694-3.","journal-title":"Behav Res Methods"},{"issue":"2","key":"1048_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/00223891.2020.1737093","volume":"103","author":"ONE Kjell","year":"2021","unstructured":"Kjell ONE, Diener E. Abbreviated three-item versions of the satisfaction with life scale and the harmony in life scale yield as strong psychometric properties as the original scales. J Pers Assess. 2021;103(2):183\u201394. https:\/\/doi.org\/10.1080\/00223891.2020.1737093.","journal-title":"J Pers Assess"},{"key":"1048_CR43","doi-asserted-by":"publisher","first-page":"111368","DOI":"10.1016\/j.jclinepi.2024.111368","volume":"171","author":"A Richter","year":"2024","unstructured":"Richter A, Ulbricht S, Brockhaus S. Categorization of continuous covariates and complex regression models-friends or foes in intersectionality research. J Clin Epidemiol. 2024;171:111368. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111368.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1048_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/sim.2331","volume":"25","author":"P Royston","year":"2006","unstructured":"Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med. 2006;25(1):127\u201341. https:\/\/doi.org\/10.1002\/sim.2331.","journal-title":"Stat Med"},{"issue":"3","key":"1048_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ejsp.2752","volume":"51","author":"A Lovakov","year":"2021","unstructured":"Lovakov A, Agadullina ER. Empirically derived guidelines for effect size interpretation in social psychology. Eur J Soc Psychol. 2021;51(3):485\u2013504. https:\/\/doi.org\/10.1002\/ejsp.2752.","journal-title":"Eur J Soc Psychol"},{"key":"1048_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.paid.2016.06.069","volume":"102","author":"GE Gignac","year":"2016","unstructured":"GignacGE. Effect size guidelines for individual differences research. Pers Indiv Differ. 2016;102:74\u20138. . https:\/\/doi.org\/10.1016\/j.paid.2016.06.069","journal-title":"Pers Indiv Differ"},{"issue":"12","key":"1048_CR47","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1177\/0269881116662634","volume":"30","author":"TM Carbonaro","year":"2016","unstructured":"Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences. J Psychopharmacol. 2016;30(12):1268\u201378. https:\/\/doi.org\/10.1177\/0269881116662634.","journal-title":"J Psychopharmacol"},{"key":"1048_CR48","doi-asserted-by":"publisher","unstructured":"Bleidorn, W., Schwaba, T., Zheng, A., Hopwood, C. J., Sosa, S. S., Roberts, B. W., & others. (2022). Personality stability and change: A meta-analysis of longitudinal studies. Psychological Bulletin, 148(7\u20138), 588\u2013619 https:\/\/doi.org\/10.1037\/bul0000365","DOI":"10.1037\/bul0000365"},{"key":"1048_CR49","doi-asserted-by":"publisher","unstructured":"Steinberg, L. (2001). We know some things: Parent\u2013adolescent relationships in retrospect and prospect. Journal of Research on Adolescence, 11(1), 1\u201319 https:\/\/doi.org\/10.1111\/1532-7795.00001","DOI":"10.1111\/1532-7795.00001"},{"key":"1048_CR50","doi-asserted-by":"publisher","unstructured":"LaursenB, Collins WA. (2009). Parent\u2013child relationships during adolescence. In R. M. Lerner & L. Steinberg, editors, Handbook of adolescent psychology: Contextual influences on adolescent development (3rd ed., pp. 3\u201342). John Wiley & Sons https:\/\/doi.org\/10.1002\/9780470479193.adlpsy002002","DOI":"10.1002\/9780470479193.adlpsy002002"},{"issue":"12","key":"1048_CR51","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/0269881116677852","volume":"30","author":"I Hartogsohn","year":"2016","unstructured":"Hartogsohn I. Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology. J Psychopharmacol. 2016;30(12):1259\u201367. https:\/\/doi.org\/10.1177\/0269881116677852.","journal-title":"J Psychopharmacol"}],"container-title":["Child and Adolescent Psychiatry and Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13034-026-01048-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13034-026-01048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13034-026-01048-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:46:31Z","timestamp":1781635591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13034-026-01048-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1048"],"URL":"https:\/\/doi.org\/10.1186\/s13034-026-01048-x","relation":{},"ISSN":["1753-2000"],"issn-type":[{"value":"1753-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}